These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3647 related items for PubMed ID: 15351577

  • 1. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 2. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [Abstract] [Full Text] [Related]

  • 3. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H.
    Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582
    [Abstract] [Full Text] [Related]

  • 4. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ.
    J Urol; 1998 Nov 01; 160(5):1673-7. PubMed ID: 9783929
    [Abstract] [Full Text] [Related]

  • 5. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.
    Cancer; 2004 Dec 01; 101(11):2540-8. PubMed ID: 15481058
    [Abstract] [Full Text] [Related]

  • 6. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN, Pansadoro V, Calabrò F, Schnetzer S, Giannarelli D, Emiliozzi P, De Paula F, Scarpone P, De Carli P, Pizzo M, Platania A, Amini M.
    Cancer; 2003 Apr 01; 97(7):1644-52. PubMed ID: 12655521
    [Abstract] [Full Text] [Related]

  • 7. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
    Prié L, Gaston R, Ferrière JM, Richaud P, Bui BN, Guillou ML.
    Cancer Radiother; 1998 Apr 01; 2 Suppl 1():62s-66s. PubMed ID: 9749081
    [Abstract] [Full Text] [Related]

  • 8. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495
    [Abstract] [Full Text] [Related]

  • 9. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    Maarouf AM, Khalil S, Salem EA, ElAdl M, Nawar N, Zaiton F.
    BJU Int; 2011 May 01; 107(10):1605-10. PubMed ID: 20825396
    [Abstract] [Full Text] [Related]

  • 10. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N.
    J Urol; 1996 Jun 01; 155(6):1897-902. PubMed ID: 8618282
    [Abstract] [Full Text] [Related]

  • 11. [Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?].
    Chrétien Y, Mejean A, Durdux C, Dufour B, Housset M.
    J Urol (Paris); 1996 Jun 01; 102(1):3-8. PubMed ID: 8763598
    [Abstract] [Full Text] [Related]

  • 12. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD, Petrylak DP, Singh P, Bagiella E, O'Toole KM, Benson MC, Olsson CA.
    J Urol; 2000 May 01; 163(5):1413-8. PubMed ID: 10751847
    [Abstract] [Full Text] [Related]

  • 13. Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up.
    Given RW, Parsons JT, McCarley D, Wajsman Z.
    Urology; 1995 Oct 01; 46(4):499-504; discussion 504-5. PubMed ID: 7571218
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].
    Chauvet B, Félix-Faure C, Davin JL, Berger C, Vincent P, Reboul F.
    Cancer Radiother; 1998 Apr 01; 2 Suppl 1():77s-81s. PubMed ID: 9749084
    [Abstract] [Full Text] [Related]

  • 15. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B, Brewer Y, Félix-Faure C, Davin JL, Choquenet C, Reboul F.
    J Urol; 1996 Oct 01; 156(4):1258-62. PubMed ID: 8808849
    [Abstract] [Full Text] [Related]

  • 16. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1998 Dec 01; 8(6):1007-11. PubMed ID: 9894259
    [Abstract] [Full Text] [Related]

  • 17. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.
    Serretta V, Lo Greco G, Pavone C, Pavone-Macaluso M.
    J Urol; 1998 Apr 01; 159(4):1187-91. PubMed ID: 9507829
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F, Reese J, Torti FM.
    J Urol; 1996 Feb 01; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [Abstract] [Full Text] [Related]

  • 19. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD.
    Cancer; 2012 Aug 15; 118(16):3920-7. PubMed ID: 22614698
    [Abstract] [Full Text] [Related]

  • 20. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YS.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):442-8. PubMed ID: 19307067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 183.